Nellore, Nov. 25: In a bid to stop tuberculosis from becoming multi drug resistant, a charitable organisation has been roping in the services of locals to monitor the TB patients in Nellore. The organisation, Damien Foundation India Trust (DFIT) has been entrusting the job of administering the drugs for the patients to the locals.

Cured patients to generate awareness among masses

Against a target of detecting 3,984 tuberculosis (TB) patients in the current year, given to Sangrur district in the light of annual risk of TB infection (ARTI) survey (257 patients per lakh per year), as many as 1,680 TB patients, including 591 highly infectious, have been detected.

Participants in a round table stressed the need for identifying tuberculosis infected people to curb spread of the disease.
Many TB patients could not be identified due to ignorance, they said while talking in the meeting titled

According to WHO

MPA Pir Amjad Hussain Jilani has said that people are not getting their children vaccinated against tuberculosis due to unawareness about the disease, and stressed the need for holding seminars, workshops and conventions in the rural areas to make people health-conscious.

A day-long workshop on Anti-Tuberculosis (T.B) for journalists, government officers, social workers was held at Chuadanga Press Club auditorium hall on Tuesday.

Ranked eighth among the highest TB (tuberculosis) burdened countries in the world, Pakistan faces a $100.36 million funding gap for the next five years to fight the lung disease that causes most female deaths as a single infectious agent than all other causes of maternal mortality.

NEW DELHI

P B Jayakumar / Mumbai September 17, 2008, 1:02 IST

Piramal Life Sciences, the demerged research arm of pharmaceutical major Nicholas Piramal India (NPIL), may become the first company to successfully develop a tuberculosis drug whose leads are isolated from the living organisms found in ice brought from the Antarctica region.

"The scientists with Piramal Life Sciences (PLSL) has identified additional leads that will help to develop drugs to treat tuberculosis and other infections," revealed Swati Piramal, director, Nicholas Piramal.